ETIENNE KENFACK: Open Payments
NPI 1033677679 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 52 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $551 · 2025 $1,015
Food & beverage: $615Honoraria: $400
| Company | Payments | Amount |
|---|---|---|
| PROTEGA PHARMACEUTIALS INC | 6 | $450 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $266 |
| SCILEX PHARMACEUTICALS INC. | 6 | $101 |
| Forte Bio-Pharma LLC | 6 | $98 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $46 |
| Valinor Pharma, LLC | 2 | $36 |
| Averitas Pharma Inc. | 1 | $17 |
Products named: ROXYBOND, RELISTOR, ZTLido, PROLATE, JOURNAVX, MOVANTIK, QUTENZA, TANLOR.
Industry payments across NJ — which companies pay providers there.
